GO:0001605 adrenomedullin receptor activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0001605 adrenomedullin receptor activity is a molecular function defined as combining with adrenomedullin to initiate a change in cell activity.
The functional adrenomedullin receptor is a heteromer of calcitonin receptor-like receptor (CALCRL) and a receptor activity-modifying protein (RAMP2 or RAMP3).
Adrenomedullin signaling through CALCRL/RAMP2 is a key endothelial pathway controlling vascular tone, blood pressure, and insulin sensitivity.
RAMP2 and RAMP3 dictate ligand selectivity and receptor trafficking, and their dysfunction is linked to acute respiratory distress syndrome (ARDS).
The receptor couples to Gs and raises cAMP, and also engages other signaling cascades depending on cellular context.
CRISPR knockout, point mutation, knock-in, and overexpression models are essential for dissecting adrenomedullin receptor function in disease.

Description

Adrenomedullin receptor activity (GO:0001605) is a molecular function that mediates the cellular response to the peptide hormone adrenomedullin. This activity is not carried by a single polypeptide but by a heteromeric complex formed by the calcitonin receptor-like receptor (CALCRL) and a receptor activity-modifying protein (RAMP), most commonly RAMP2 or RAMP3. The receptor is a class B G protein-coupled receptor (GPCR) that, upon binding adrenomedullin, initiates intracellular signaling to modulate vascular tone, fluid homeostasis, and cell survival. Researchers study GO:0001605 because it sits at the intersection of cardiovascular physiology, metabolic disease, and inflammation. Understanding its mechanism and regulation is critical for developing therapeutics that target adrenomedullin signaling in conditions such as hypertension, diabetes, and acute respiratory distress syndrome.

adrenomedullin receptor activity At A Glance

GO ID GO:0001605
GO term adrenomedullin receptor activity
Ontology molecular_function
Synonym G10D receptor
Definition Combining with adrenomedullin to initiate a change in cell activity.
Major function Binds adrenomedullin and activates intracellular signaling, primarily via Gs/cAMP.
Core receptor complex CALCRL (calcitonin receptor-like receptor) + RAMP2 or RAMP3.
Ligand Adrenomedullin (ADM).
Tissue expression Highly expressed in endothelial cells and vascular smooth muscle.

What Is GO:0001605?

In simple terms, adrenomedullin receptor activity is the ability of a cell-surface receptor complex to bind the hormone adrenomedullin and trigger a change inside the cell. According to the Gene Ontology, this function is defined as combining with adrenomedullin to initiate a change in cell activity. The receptor is a heterodimer of CALCRL and a RAMP protein, and the specific RAMP determines whether the complex responds to adrenomedullin or related peptides.

Why Is adrenomedullin receptor activity Important in Cell Biology?

Adrenomedullin receptor activity is a central regulator of cardiovascular homeostasis and metabolic function. It controls vascular tone and blood pressure through endothelial signaling, and its dysregulation contributes to obesity-associated insulin resistance and diabetes. The receptor also plays a protective role in endothelial barrier function, and RAMP2/3 dysfunction is implicated in acute respiratory distress syndrome. Because of its broad physiological impact, GO:0001605 is a high-value target for both basic research and therapeutic development.
Regulates vascular tone and blood pressure via shear stress-induced endothelial adrenomedullin signaling.
Mediates obesity-associated insulin resistance and diabetes through endothelial insulin resistance.
Protects endothelial barrier integrity; RAMP2/3 dysfunction is linked to ARDS.
Controls ligand selectivity through RAMP2 vs RAMP3 incorporation.
Couples to Gs to raise cAMP and can also activate other pathways.
Involved in fluid homeostasis and cell survival.
Provides a druggable target for cardiovascular and metabolic diseases.
Essential for understanding class B GPCR pharmacology.
RAMP proteins modulate receptor trafficking and glycosylation.
Adrenomedullin signaling is conserved and relevant across species.

What Happens During adrenomedullin receptor activity?

Ligand binding and receptor activation
In simple terms: Adrenomedullin binds to the CALCRL/RAMP complex on the cell surface, switching the receptor on.
Adrenomedullin, a 52-amino-acid peptide hormone, binds with high affinity to the heterodimeric receptor formed by CALCRL and RAMP2 or RAMP3. The RAMP subunit is critical for ligand recognition and determines whether the receptor responds to adrenomedullin or related peptides such as CGRP. Upon binding, the receptor undergoes conformational changes that activate intracellular heterotrimeric G proteins.
G protein coupling and second messenger generation
In simple terms: Once activated, the receptor turns on G proteins that produce cAMP, a key signaling molecule.
The adrenomedullin receptor primarily couples to Gs, leading to activation of adenylyl cyclase and increased intracellular cAMP levels. This cAMP surge activates protein kinase A (PKA) and downstream effectors that modulate vascular relaxation, endothelial permeability, and gene expression. In some cellular contexts, the receptor can also couple to other G proteins, but Gs/cAMP is the canonical pathway.
Receptor internalization and trafficking
In simple terms: After signaling, the receptor is pulled inside the cell to be recycled or degraded.
Following prolonged agonist exposure, the CALCRL/RAMP complex undergoes internalization, a process influenced by the specific RAMP subtype. RAMP2 and RAMP3 differentially regulate receptor trafficking and recycling, which affects the duration and intensity of signaling. This regulation is important for maintaining vascular responsiveness and preventing desensitization.
Physiological effects on vascular tone
In simple terms: The receptor helps blood vessels relax and controls blood pressure.
Shear stress-induced endothelial adrenomedullin signaling activates the receptor to promote vasodilation and regulate blood pressure. This pathway involves endothelial nitric oxide synthase (eNOS) activation and nitric oxide production, which relaxes smooth muscle. Disruption of this signaling leads to hypertension and vascular dysfunction.
Metabolic regulation and insulin sensitivity
In simple terms: The receptor also affects how the body responds to insulin, linking it to diabetes.
Endothelial adrenomedullin signaling induces insulin resistance in obesity, contributing to diabetes pathogenesis. Adrenomedullin receptor activation in endothelial cells impairs insulin delivery to muscle and adipose tissue, reducing glucose uptake. This identifies GO:0001605 as a potential therapeutic target for metabolic disease.

Key Genes Involved in GO:0001605 adrenomedullin receptor activity

The following genes and proteins are central to adrenomedullin receptor activity and its regulation.
GeneMajor RoleResearch Relevance
ADMEncodes adrenomedullin, the endogenous ligandLigand for receptor activation; knockout models show vascular defects
CALCRLCalcitonin receptor-like receptor; core GPCR subunitEssential for adrenomedullin binding and signaling
RAMP2Receptor activity-modifying protein 2Determines adrenomedullin selectivity; knockout causes vascular abnormalities
RAMP3Receptor activity-modifying protein 3Modulates receptor trafficking and ligand specificity
CRCPCalcitonin receptor component proteinEnhances coupling to Gs and cAMP production
GNA SGs alpha subunitMediates cAMP generation upon receptor activation
ADCYAdenylyl cyclaseProduces cAMP downstream of Gs
PRKACAProtein kinase A catalytic subunitPhosphorylates targets to modulate vascular tone
NOS3Endothelial nitric oxide synthaseProduces nitric oxide for vasodilation
INSRInsulin receptorCross-talk with adrenomedullin signaling in endothelium
AKTProtein kinase BMediates metabolic effects of insulin resistance
VEGFAVascular endothelial growth factor AInteracts with adrenomedullin pathway in angiogenesis
EDN1Endothelin-1Opposes adrenomedullin vasodilation
AGTR1Angiotensin II receptor type 1Counter-regulates vascular tone
RAMP1Receptor activity-modifying protein 1Forms CGRP receptor; related family member
CLRCalcitonin receptorRelated class B GPCR; context for selectivity
GNAIGi alpha subunitPotential alternative coupling

How Is adrenomedullin receptor activity Regulated?

Adrenomedullin receptor activity is regulated at multiple levels. RAMP2 and RAMP3 expression levels control the composition and trafficking of the receptor complex, thereby influencing ligand selectivity and signaling duration. Shear stress increases endothelial adrenomedullin expression and receptor activation, providing mechanical regulation of vascular tone. In obesity, hyperinsulinemia and inflammatory cytokines can modulate receptor sensitivity, contributing to endothelial insulin resistance. Additionally, receptor desensitization and internalization are regulated by GRK-mediated phosphorylation and beta-arrestin recruitment, although specific details for CALCRL/RAMP are still being elucidated.

adrenomedullin receptor activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
ADMHypertension, diabetesAdm knockout or overexpression mice
CALCRLCardiovascular dysfunctionEndothelial-specific Calcrl knockout
RAMP2ARDS, vascular leakRamp2 knockout or point mutation
RAMP3ARDS, receptor traffickingRamp3 knockout or tagged knock-in
INSRInsulin resistanceEndothelial Insr knockout
Cardiovascular disease and hypertension
Adrenomedullin receptor activity is critical for maintaining vascular tone and blood pressure. Shear stress-induced endothelial adrenomedullin signaling activates CALCRL/RAMP2 to promote vasodilation via nitric oxide. Dysregulation of this pathway leads to hypertension and endothelial dysfunction, making GO:0001605 a therapeutic target for cardiovascular disease.
Obesity-associated diabetes and insulin resistance
Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. In obesity, increased adrenomedullin signaling impairs insulin delivery to skeletal muscle and adipose tissue, reducing glucose uptake. Targeting the adrenomedullin receptor could improve insulin sensitivity in diabetic patients.
Acute respiratory distress syndrome (ARDS)
RAMP2 and RAMP3, essential subunits of the adrenomedullin receptor, play critical roles in the pathogenesis of ARDS. Loss of RAMP2/3 function disrupts endothelial barrier integrity, leading to pulmonary edema and inflammation. Modulating adrenomedullin receptor activity may offer therapeutic benefit in ARDS.

From adrenomedullin receptor activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does CALCRL mediate adrenomedullin-induced vasodilation?Endothelial-specific CALCRL knockout mouse
What is the role of RAMP2 vs RAMP3 in ligand selectivity?RAMP2 or RAMP3 point-mutation knock-in mice
Does adrenomedullin overexpression cause insulin resistance?Inducible ADM overexpression mouse
How does receptor trafficking affect signaling duration?Tagged RAMP3 knock-in for live imaging
Can CRISPR activation of ADM rescue hypertension?CRISPRa overexpression in endothelial cells
What are the off-target effects of RAMP2 knockout?Whole-body RAMP2 knockout with rescue

How to Study the adrenomedullin receptor activity Process

MethodWhat It MeasuresTypical Application
cAMP GloSensorIntracellular cAMP levelsReceptor activation by adrenomedullin
CRISPR knockoutGene function lossEndothelial CALCRL knockout
Knock-in point mutationSpecific residue functionRAMP2 selectivity mutants
RNA-seqTranscriptional changesAdrenomedullin-induced gene expression
ProteomicsProtein interactionsCALCRL/RAMP complex partners
TelemetryBlood pressure and heart rateIn vivo receptor function
ImmunofluorescenceReceptor localizationRAMP3 trafficking
ELISAAdrenomedullin peptide levelsBiomarker in ARDS
cAMP assays for receptor activation
The canonical readout for adrenomedullin receptor activity is intracellular cAMP measurement using luminescent or fluorescent biosensors. These assays quantify Gs coupling and can be used to screen agonists and antagonists.
CRISPR knockout and knock-in models
CRISPR/Cas9-mediated knockout of CALCRL, RAMP2, or RAMP3 in endothelial cells or mice allows dissection of receptor function in vivo. Knock-in of point mutations can reveal residues critical for ligand binding or G protein coupling.
Proteomic and interactomic analysis
Affinity purification coupled to mass spectrometry can identify novel interacting partners of the CALCRL/RAMP complex, providing insight into signaling crosstalk. Phosphoproteomics can map downstream phosphorylation events.
In vivo hemodynamic measurements
Telemetry and tail-cuff plethysmography in genetically modified mice assess the impact of receptor mutations on blood pressure and heart rate. These methods are essential for translating molecular findings to physiology.

How CRISPR Can Be Used to Study GO:0001605 adrenomedullin receptor activity

Knockout

CRISPR knockout of CALCRL or RAMP2 in endothelial cells abolishes adrenomedullin receptor activity, leading to loss of cAMP production and vasodilation. These models are used to study hypertension and ARDS.

Point Mutation

Point mutations in RAMP2 or CALCRL can disrupt ligand binding or G protein coupling without affecting receptor expression. Such models help map the functional domains of the receptor complex.

Knock-in

Knock-in of tagged RAMP3 (e.g., HA or GFP) allows real-time tracking of receptor trafficking and internalization in live cells. This is valuable for understanding desensitization mechanisms.

Overexpression

Overexpression of ADM or CALCRL/RAMP2 using CRISPR activation or lentiviral vectors enhances receptor signaling and can model conditions of adrenomedullin excess, such as obesity-associated insulin resistance.

How EDITGENE Supports adrenomedullin receptor activity Research

Researchers studying adrenomedullin receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for adrenomedullin receptor activity research.

Frequently Asked Questions About adrenomedullin receptor activity

Adrenomedullin receptor activity (GO:0001605) is the molecular function of binding the hormone adrenomedullin and initiating a change in cell activity, primarily through the CALCRL/RAMP2 or CALCRL/RAMP3 heterodimer.
The core genes are ADM (ligand), CALCRL (receptor), and RAMP2 or RAMP3 (modifiers). Other related genes include CRCP, GNAS, and NOS3.
It couples to Gs to activate adenylyl cyclase and increase cAMP, leading to PKA activation and downstream effects on vascular tone and metabolism.
It is linked to hypertension, obesity-associated diabetes, and acute respiratory distress syndrome (ARDS).
RAMP2 and RAMP3 are essential subunits that determine ligand selectivity, receptor trafficking, and signaling duration.
Common methods include cAMP assays, CRISPR knockout of CALCRL or RAMP2, and in vivo telemetry in mice.
G10D receptor is a synonym for adrenomedullin receptor activity (GO:0001605).
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to dissect receptor function and disease mechanisms.
They are highly expressed in endothelial cells and vascular smooth muscle cells, but also found in other tissues.
It mediates shear stress-induced vasodilation and regulates vascular tone, directly impacting blood pressure.

Conclusion

Adrenomedullin receptor activity (GO:0001605) is a fundamental molecular function that controls vascular tone, metabolic homeostasis, and endothelial barrier integrity. The heteromeric CALCRL/RAMP2 or CALCRL/RAMP3 complex binds adrenomedullin and signals primarily through Gs/cAMP, with RAMP subunits dictating ligand specificity and trafficking. Dysregulation of this pathway contributes to hypertension, diabetes, and ARDS, making it a compelling therapeutic target. Continued research using CRISPR models and advanced bioinformatics will further illuminate its role in health and disease.

References

  1. 1. Cho H et al.. 2025. Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes.. Science 387(6734):674-682 PMID: 39913566
  2. 2. Kasahara T et al.. 2024. Receptor activity-modifying proteins of adrenomedullin (RAMP2/3): Roles in the pathogenesis of ARDS.. Peptides 171:171118 PMID: 38012983
  3. 3. Muff R et al.. 2003. Adrenomedullin selectivity of calcitonin-like receptor/receptor activity modifying proteins.. Hypertens Res 26 Suppl:S3-8 PMID: 12630805
  4. 4. Gibbons C et al.. 2007. Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling.. Mol Endocrinol 21(4):783-96 PMID: 17053041
  5. 5. Born W et al.. 2002. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins.. Recept Channels 8(3-4):201-9 PMID: 12529937
  6. 6. Iring A et al.. 2019. Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure.. J Clin Invest 129(7):2775-2791 PMID: 31205027
  7. 7. Born W et al.. 2002. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).. Microsc Res Tech 57(1):14-22 PMID: 11921352
  8. 8. Smith DM et al.. 2002. Adrenomedullin: receptor and signal transduction.. Biochem Soc Trans 30(4):432-7 PMID: 12196109
Contact Us
*
*
*
*
How did you hear about us: